← Back to Search

Patient Navigation Program for Chronic Diseases (ENCOMPASS Trial)

N/A
Waitlist Available
Led By Kerry A McBrien, MD, MPH
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Established ischemic heart disease
Congestive heart failure
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6- and 12-months post-implementation
Awards & highlights

ENCOMPASS Trial Summary

This trial is evaluating a patient navigation program to see if it can help improve care and health outcomes for high-risk patients with chronic disease.

Who is the study for?
This trial is for adults over 18 with chronic diseases like severe lung conditions, heart failure, high blood pressure, kidney disease, or poorly controlled diabetes. They must have had multiple visits for their condition in the past year and be able to give informed consent. It's not open to those in long-term care facilities or if a doctor thinks it's not suitable.Check my eligibility
What is being tested?
The ENCOMPASS Intervention is being tested. It pairs patients with complex health issues with community health navigators who help them understand and manage their conditions better by improving communication with healthcare providers and navigating the health system.See study design
What are the potential side effects?
Since this intervention involves patient education and support rather than medication, traditional side effects are not expected. However, there may be indirect effects on stress levels or emotional well-being due to changes in healthcare management.

ENCOMPASS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with heart disease caused by narrowed heart arteries.
Select...
I have been diagnosed with congestive heart failure.
Select...
I have COPD or asthma and visited a doctor for it at least twice last year.
Select...
My kidney function is reduced, with an eGFR below 45 mL/min/1.73m2 in the last year.
Select...
My diabetes has been poorly controlled, with an A1C over 9% in the past year.
Select...
I am 18 years old or older.

ENCOMPASS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6- and 12-months post-implementation
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6- and 12-months post-implementation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acute care utilization
Secondary outcome measures
Acute care costs
Anxiety score
Depression score
+17 more

ENCOMPASS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ENCOMPASS programExperimental Treatment1 Intervention
Clinics assigned to the intervention will receive the ENCOMPASS intervention and a CHN will be matched to their clinic and be available to patients that meet the eligibility criteria.
Group II: Usual careActive Control1 Intervention
Patients not enrolled in the intervention will continue to receive care as usual until their clinic receives the intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ENCOMPASS Intervention
2018
N/A
~180

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
796 Previous Clinical Trials
874,723 Total Patients Enrolled
Canadian Diabetes AssociationOTHER
42 Previous Clinical Trials
11,146 Total Patients Enrolled
Alberta Innovates Health SolutionsOTHER
53 Previous Clinical Trials
94,252 Total Patients Enrolled

Media Library

ENCOMPASS Intervention Clinical Trial Eligibility Overview. Trial Name: NCT03077386 — N/A
Type 2 Diabetes Research Study Groups: ENCOMPASS program, Usual care
Type 2 Diabetes Clinical Trial 2023: ENCOMPASS Intervention Highlights & Side Effects. Trial Name: NCT03077386 — N/A
ENCOMPASS Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03077386 — N/A
~25 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top